Michael J. Fox Foundation for Parkinson's Research Honored with Advocacy/Policy Award from Reagan-Udall Foundation for the FDA - PR Newswire
NEW YORK, Dec. 9, 2020 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has received the Advocacy/Policy Award from the Reagan-Udall Foundation for the Food and Drug Administration. MJFF is the second organization ever to receive this award, which honors individuals or groups that have made an impact to improve public health through advocacy and public policy. It was conferred to MJFF at the 2020 Innovations in Regulatory Science Awards Dinner, which was held virtually on Tuesday, December 8, 2020.
Foundation leadership including Michael J. Fox, Co-Founder and Executive Vice Chairman Deborah W. Brooks and CEO Todd Sherer, PhD, jointly accepted the award on behalf of the hundreds of thousands of individuals — patients, families, researchers and partners — who enable our work.
"This recognition means the world to us," said Michael J. Fox. "Twenty years ago, laying out the blueprint for the Foundation, we had no idea it would grow to this extent. With the help of countless individuals, we set out to do whatever it takes to speed tangible results for people and families with PD. If it matters to people with Parkinson's, we're on it."